Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Epithelial-Mesenchymal Transition in the Resistance to Somatostatin Receptor Ligands in Acromegaly

  • Gil Ortega, Joan|||0000-0003-1030-9119
  • Jordà, Mireia|||0000-0003-3709-1850
  • Soldevila i Madorell, Berta|||0000-0002-4582-4201
  • Puig Domingo, Manuel|||0000-0002-6744-7195
Epithelial-mesenchymal transition (EMT) is a dynamic process by which epithelial cells loss their phenotype and acquire mesenchymal traits, including increased migratory and invasive capacities. EMT is involved in physiological processes, such as embryogenesis and wound healing, and in pathological processes such as cancer, playing a pivotal role in tumor progression and metastasis. Pituitary tumors, although typically benign, can be locally invasive. Different studies have shown the association of EMT with increased tumor size and invasion in pituitary tumors, and in particular with a poor response to Somatostatin Receptor Ligands (SRLs) treatment in GH-producing pituitary tumors, the main cause of acromegaly. This review will summarize the current knowledge regarding EMT and SRLs resistance in acromegaly and, based on this relation, will suggest new biomarkers and possible therapies to SRLs resistant tumors.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Data mining analyses for precision medicine in acromegaly, a proof of concept

  • Gil Ortega, Joan|||0000-0003-1030-9119
  • Marqués Pamies, Montserrat|||0000-0001-6391-5070
  • Sampedro Núñez, Miguel Antonio
  • Webb, S. M.|||0000-0001-7052-6436
  • Serra, Guillermo
  • Salinas, Isabel
  • Blanco, Alberto
  • Valassi, Elena|||0000-0002-3864-0105
  • Carrato, Cristina|||0000-0002-1953-8287
  • Picó Alfonso, Antonio M.|||0000-0002-7549-7563
  • García Martínez, Araceli
  • Martel-Duguech, Luciana|||0000-0001-6959-9726
  • Sardon, Teresa|||0000-0002-5935-9312
  • Simó-Servat, Andreu|||0000-0002-1092-1327
  • Biagetti, Betina|||0000-0002-8837-4343
  • Villabona, Carles|||0000-0002-3836-2096
  • Cámara, Rosa|||0000-0002-3289-3400
  • Fajardo-Montañana, Carmen|||0000-0002-0784-0761
  • Álvarez-Escolá, Cristina|||0000-0002-4684-1652
  • Lamas, Cristina|||0000-0003-4622-9508
  • Alvarez, Clara V.
  • Bernabeu Morón, Ignacio|||0000-0001-8421-7394
  • Marazuela, Mónica|||0000-0003-1158-9618
  • Jordà, Mireia|||0000-0003-3709-1850
  • Puig Domingo, Manuel|||0000-0002-6744-7195
Predicting which acromegaly patients could benefit from somatostatin receptor ligands (SRL) is a must for personalized medicine. Although many biomarkers linked to SRL response have been identified, there is no consensus criterion on how to assign this pharmacologic treatment according to biomarker levels. Our aim is to provide better predictive tools for an accurate acromegaly patient stratification regarding the ability to respond to SRL. We took advantage of a multicenter study of 71 acromegaly patients and we used advanced mathematical modelling to predict SRL response combining molecular and clinical information. Different models of patient stratification were obtained, with a much higher accuracy when the studied cohort is fragmented according to relevant clinical characteristics. Considering all the models, a patient stratification based on the extrasellar growth of the tumor, sex, age and the expression of E-cadherin, GHRL, IN1-GHRL, DRD2, SSTR5 and PEBP1 is proposed, with accuracies that stand between 71 to 95%. In conclusion, the use of data mining could be very useful for implementation of personalized medicine in acromegaly through an interdisciplinary work between computer science, mathematics, biology and medicine. This new methodology opens a door to more precise and personalized medicine for acromegaly patients.